| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| BLUEJAY DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 10.11. | Bluejay Diagnostics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.11. | Bluejay Diagnostics reports progress on sepsis test clinical trial | 4 | Investing.com | ||
| 10.11. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Corporate Update: Advancing Clinical Milestones and Strategic Partnerships | 74 | GlobeNewswire (Europe) | Company focused on advancing clinical milestones and strategic partnerships, with goal of positioning itself for future FDA clearance and product commercialization.Patient enrollment in SYMON-II clinical... ► Artikel lesen | |
| 07.11. | Bluejay Diagnostics, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 23.10. | Bluejay Diagnostics files to sell 6.93M shares of common stock for holders | 2 | Seeking Alpha | ||
| 10.10. | Bluejay Diagnostics closes $4.5 million private placement | 1 | Investing.com | ||
| 10.10. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules | 2 | GlobeNewswire (USA) | ||
| 09.10. | Bluejay Diagnostics raises $4.5 million in private placement | 3 | Investing.com | ||
| 09.10. | Bluejay Diagnostics sichert sich 4,5 Millionen US-Dollar durch Privatplatzierung | 2 | Investing.com Deutsch | ||
| 09.10. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules | 1 | GlobeNewswire (USA) | ||
| 09.10. | Bluejay Diagnostics stock soars after expanding manufacturing partnership | 2 | Investing.com | ||
| 09.10. | Bluejay Diagnostics expands partnership with SanyoSeiko for Symphony platform | 4 | Investing.com | ||
| 09.10. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform | 182 | GlobeNewswire (Europe) | ACTON, Mass. and YAMANASHI, Japan, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay"), a medical diagnostics company focused on developing rapid near-patient testing... ► Artikel lesen | |
| 09.10. | Bluejay Diagnostics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.08. | Bluejay Diagnostics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 09.08. | Bluejay Diagnostics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 08.08. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Provides Second Quarter Business and Corporate Update | 322 | GlobeNewswire (Europe) | ACTON, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay" or the "Company"), a medical diagnostics company developing near-patient solutions for critical... ► Artikel lesen | |
| 07.08. | Bluejay Diagnostics, Inc. - 10-Q, Quarterly Report | 10 | SEC Filings | ||
| 28.07. | Bluejay Diagnostics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 03.06. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Provides Mid-Year Business and Corporate Update | 319 | GlobeNewswire (Europe) | ACTON, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay" or the "Company"), a medical diagnostics company developing rapid near-patient testing solutions... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 46,100 | +2,44 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hatCarl Zeiss Meditec auf "Overweight" mit einem Kursziel von 52 Euro belassen. Die Aktienkurse der europäischen Medizintechnik-Unternehmen... ► Artikel lesen | |
| GE HEALTHCARE TECHNOLOGIES | 69,80 | +2,83 % | 2,3 Milliarden US-Dollar: GE Healthcare: Dieser Milliarden-Deal soll den Umsatz explodieren lassen! | © Foto: Picture AllianceGE Healthcare übernimmt Intelerad und stärkt damit sein Netzwerk für medizinische Bildgebung, treibt den Ausbau von KI-Diensten voran und erweitert sein cloudbasiertes Angebot.GE... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 2,092 | +0,63 % | Clover Health Investments, Corp.: Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service | WILMINGTON, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover," "Clover Health" or the "Company") today announced that Chelsea Clinton, the longest-serving... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 42,530 | +0,83 % | DAX-Check LIVE: BMW, RTL Group, SAP, Scout24, SFC Energy, Siemens Healthineers | Der Abwärtstrend am deutschen Aktienmarkt hat sich zum Wochenstart fortgesetzt. Sinkende Hoffnungen auf weitere Zinssenkungen sowie die Unsicherheit vor wichtigen US-Konjunkturdaten sorgten dafür, dass... ► Artikel lesen | |
| FRESENIUS | 47,660 | +0,97 % | Fresenius SE wackelt - dieser Boden sollte halten | Die Fresenius SE-Aktie steht kurz vor einer wichtigen Unterstützung. Hält der Bereich, oder droht ein Rückfall in tiefere Kursregionen Den vollständigen Artikel lesen ... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,670 | +0,65 % | BARCLAYS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für FMC von 51 auf 48 Euro gesenkt und die Einstufung auf "Equal Weight" belassen. Die Aktienkurse der europäischen... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 18,940 | +7,49 % | Alignment Healthcare stock rating upgraded by JPMorgan to Overweight | ||
| PROCEPT BIOROBOTICS | 32,450 | +8,13 % | Piper Sandler Reiterates a Buy on PROCEPT BioRobotics Corporation (PRCT) | ||
| GERRESHEIMER | 24,860 | +2,39 % | Gerresheimer-Aktie: Kurspotenzial durch den Neustart? | Aktionäre von Gerresheimer mussten zuletzt herbe Kursverluste hinnehmen. Seit dem Hoch im März mit rund 81 € ist der Kurs um mehr als zwei Drittel gesunken. Am Dienstag erholt er sich aktuell um +3... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 35,780 | +1,68 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| GENEDX | 166,90 | +3,56 % | GeneDx auf der Jefferies London Konferenz: Strategische Expansion in der Pädiatrie | ||
| NUTEX HEALTH | 122,04 | -10,97 % | Nutex Health, Inc.: Nutex Health Reports September 30, 2025 Third Quarter And Year-to-date Financial Results | Total revenue of $723.6 million for the first nine months of 2025 versus $222.3 million for the first nine months of 2024, an increase of 225.5%
Net... ► Artikel lesen | |
| PROGYNY | 27,100 | +2,92 % | Progyny, Inc.: New Men's Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action | ||
| PACS GROUP | 31,830 | +6,14 % | Morning Market Movers: Mobile-health Network Solutions, PACS Group, Brera Holdings, Cerence See Big Swings | SANTA CLARA (dpa-AFX) - At 7:55 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BILLIONTOONE | 125,06 | +4,10 % | BillionToOne, Inc.: BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares | MENLO PARK, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced... ► Artikel lesen |